Takeda Pharmaceutical Company Limited

Masanori Miwa

Ryo Fujii

Masaki Hosoya

Yuji Kawamata

Syuji Hinuma

The present invention intends to provide a screening of agonist/antagonist and the like. Specifically, the invention provides a method of screening a compound or its salt that alters the binding property between a novel G protein-coupled receptor protein or its salt, and a substance relating to cholesterol metabolism, which comprises using the receptor protein or its salt, which contains the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 14 or SEQ ID NO: 16, and the substance relating to cholesterol metabolism.

Growing community of inventors

Osaka, Japan

Masanori Miwa